Clinical trials: Toripalimab, completed
Sarcoma,Soft Tissue
Anlotinib Combined With Toripalimab in Refractory and Advanced Soft-tissue Sarcoma
Soft tissue sarcoma (STS) is a relatively rare type of malignant tumor with an incidence of 1-2/100000. For unresectable or widely disseminated advanced STS, a combined clinical trial is the best way to obtain evidence-based…
- Trial name
- NCT04172805
- Testing
- anlotinib and toripalimab
- Where
- China
- Volunteers
- 70 people
- Sponsor
- Sun Yat-sen University